Biotechnology & Medical Research

Bioheart Inc completes financing with Magna

Bioheart Inc:Closes common stock purchase agreement for a $3 mln Equity Enhancement Program (EEP) with a Magna affiliate fund, Magna Equities II, LLC (Investor).EEP allows, but does not obligate the Company to issue and sell up to $3,000,000 worth of the Company's common stock to the Investor from...

4:00pm EDT

Imprimis Pharmaceuticals Inc reports on positive clinical findings

Imprimis Pharmaceuticals Inc:Reported on clinical findings demonstrating safety and benefits of Dropless cataract surgery and provided an update resulting from recent American Academy of Ophthalmology (AAO) annual meeting held in Chicago, Illinois.Says any also announced Dropless media coverage from...

8:00am EDT

QLT Inc appoints interim Chief Executive Officer

QLT Inc:Says board member, Geoffrey F. Cox has been appointed as interim Chief Executive Officer, effective immediately.

7:00am EDT

ImmunoGen Inc reaffirms FY 2015 guidance

ImmunoGen Inc:Says that its financial guidance remains unchanged from that issued in Aug.Expects FY 2015 revenues to be between $100 million and $105 million.Expects FY 2015 net loss to be between $60 million and $65 million.FY 2015 revenue of $101 million and net loss of $64 million - Thomson...

6:30am EDT


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Thomson Reuters StreetEvents
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.